Xilio Therapeutics (XLO) Earnings Date, Estimates & Call Transcripts $0.96 +0.03 (+2.88%) Closing price 04:00 PM EasternExtended Trading$1.04 +0.08 (+7.90%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Xilio Therapeutics Earnings Summary Xilio Therapeutics released Q1 2025 earnings on May 13, 2025, reporting an EPS of -$0.18, which missed analysts' consensus estimates of $0.10 by $0.28. Quarterly revenue was reported to be $2.93 million, below the consensus estimate of $42 million. With a trailing EPS of -$0.84, Xilio Therapeutics' earnings are expected to grow next year, from ($1.14) to ($0.40) per share. Upcoming Q2 Earnings DateAug. 14Before Market OpensEstimatedConsensus EPS (May. 13) $0.10 Actual EPS (May. 13) -$0.18 Missed By -$0.28 Actual Revenue (May. 13) $2.93MQ1 2025 Earnings ResourcesQ1 2025 Earnings Report Quarterly Report (10-Q)XLO Upcoming EarningsXilio Therapeutics' next earnings date is estimated for Thursday, August 14, 2025, based on past reporting schedules. Powered by Get Xilio Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Xilio Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataXLO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.XLO Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Xilio Therapeutics Analyst EPS EstimatesCurrent Year EPS Consensus Estimate ($1.14) EPSNext Year EPS Consensus Estimate ($0.40) EPS Xilio Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/14/2025(Estimated)--------5/13/2025Q1 2025$0.10-$0.18 -$0.28-$0.18$42.00M$2.93M3/11/2025Q4 2024-$0.22-$0.20+$0.02-$0.20$2.26M$1.72M11/7/2024--$0.25-$0.22+$0.03-$0.22--8/8/2024--$0.23-$0.24 -$0.01-$0.24$30.00M$2.36M5/14/2024Q1 2024-$0.30-$0.59 -$0.29-$0.56--4/1/2024Q4 2023--$0.64 -$0.64-$0.64--11/9/2023Q3 2023-$0.76-$0.61+$0.15-$0.61--8/14/2023Q2 2023-$0.84-$0.70+$0.14-$0.70-- Xilio Therapeutics Earnings - Frequently Asked Questions When is Xilio Therapeutics's earnings date? Xilio Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 14th, 2025 based off last year's report dates. Learn more on XLO's earnings history. Did Xilio Therapeutics beat their earnings estimates last quarter? In the previous quarter, Xilio Therapeutics (NASDAQ:XLO) missed the analysts' consensus estimate of $0.10 by $0.28 with a reported earnings per share (EPS) of ($0.18). Learn more on analysts' earnings estimate vs. XLO's actual earnings. How much revenue does Xilio Therapeutics generate each year? Xilio Therapeutics (NASDAQ:XLO) has a recorded annual revenue of $9.27 million. How much profit does Xilio Therapeutics generate each year? Xilio Therapeutics (NASDAQ:XLO) has a recorded net income of -$76.40 million. XLO has generated -$0.84 earnings per share over the last four quarters. What is Xilio Therapeutics's EPS forecast for next year? Xilio Therapeutics's earnings are expected to grow from ($1.14) per share to ($0.40) per share in the next year. More Earnings Resources from MarketBeat Related Companies Eledon Pharmaceuticals Earnings Results Kodiak Sciences Earnings Results CytomX Therapeutics Earnings Results ProQR Therapeutics Earnings Results scPharmaceuticals Earnings Results DiaMedica Therapeutics Earnings Results AC Immune Earnings Results Prime Medicine Earnings Results INmune Bio Earnings Results Molecular Partners Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles CrowdStrike Stock Slips: Analyst Downgrades Before Earnings Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsAdvance Auto Parts: Did Earnings Defuse Tariff Concerns?Booz Allen Hamilton Earnings: 3 Bullish Signals for BAH StockAdvance Auto Parts Jumps on Surprise Earnings BeatAlibaba's Earnings Just Changed Everything for the StockCisco Stock Eyes New Highs in 2025 on AI, Earnings, Upgrades This page (NASDAQ:XLO) was last updated on 5/29/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredAs Bitcoin supply vanishes, this Trump-aligned token could explodeBitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xilio Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Xilio Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy XLO Stock Free XLO Stock Alerts